Médecine et maladies infectieuses
-
We compared the relapse rate at 1 year in patients with vertebral osteomyelitis with or without associated endocarditis. ⋯ In a relatively small population, we did not find significantly more relapse in the endocarditis group.
-
Medical publications about anosmia with COVID-19 are scarce. We aimed to describe the prevalence and features of anosmia in COVID-19 patients. ⋯ Anosmia was present in half of our European COVID-19 patients and was often associated with dysgeusia.
-
No therapy has yet proven effective in COVID-19. Tocilizumab (TCZ) in patients with severe COVID-19 could be an effective treatment. ⋯ Despite the small sample size and retrospective nature of the work, this result strongly suggests that TCZ may reduce the number of ICU admissions and/or mortality in patients with severe SARS-CoV-2 pneumonia.